Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
56,054,044
-
Share change
-
+1,777,014
-
Total reported value
-
$3,891,389,654
-
Put/Call ratio
-
58%
-
Price per share
-
$69.39
-
Number of holders
-
228
-
Value change
-
+$119,975,177
-
Number of buys
-
99
-
Number of sells
-
125
Institutional Holders of ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) as of Q1 2021
As of 31 Mar 2021,
ARENA PHARMECEUTICALS INC - COMMON STOCK (ARNA) was held by
228 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,054,044 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Avoro Capital Advisors LLC, LORD, ABBETT & CO. LLC, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
228
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.